Alison Joyce

1.3k total citations
23 papers, 617 citations indexed

About

Alison Joyce is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alison Joyce has authored 23 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Immunology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alison Joyce's work include Biosimilars and Bioanalytical Methods (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Protein purification and stability (6 papers). Alison Joyce is often cited by papers focused on Biosimilars and Bioanalytical Methods (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Protein purification and stability (6 papers). Alison Joyce collaborates with scholars based in United States, United Kingdom and Belgium. Alison Joyce's co-authors include David Yates, Sheldon S. Leung, Mengmeng Wang, Xin Xu, Denise M. O’Hara, Tong‐Yuan Yang, Alvydas Mikulskis, Saloumeh K Fischer, Mark Spengler and Zhuang Yao and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cell Metabolism.

In The Last Decade

Alison Joyce

23 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Joyce United States 13 305 193 179 110 80 23 617
Jonas Hahn Germany 17 377 1.2× 58 0.3× 719 4.0× 104 0.9× 47 0.6× 27 1.1k
Janine Woytschak Switzerland 7 136 0.4× 92 0.5× 416 2.3× 54 0.5× 26 0.3× 8 635
Alex D. Colella Australia 15 170 0.6× 58 0.3× 105 0.6× 91 0.8× 17 0.2× 26 567
Dae-Kyoung Choi South Korea 18 377 1.2× 26 0.1× 246 1.4× 44 0.4× 18 0.2× 38 1.2k
Andyna Vernet United States 7 401 1.3× 61 0.3× 78 0.4× 59 0.5× 173 2.2× 11 794
C. Baerwald Germany 8 295 1.0× 27 0.1× 240 1.3× 49 0.4× 21 0.3× 14 637
Norikatsu Mizumoto United States 11 278 0.9× 29 0.2× 508 2.8× 66 0.6× 41 0.5× 15 1.0k
Wesley F. Obritsch United States 10 105 0.3× 121 0.6× 260 1.5× 18 0.2× 17 0.2× 12 569
Divya Sagar United States 13 159 0.5× 73 0.4× 388 2.2× 47 0.4× 21 0.3× 19 713
Leyre Falto‐Aizpurua United States 16 64 0.2× 77 0.4× 71 0.4× 56 0.5× 36 0.5× 47 701

Countries citing papers authored by Alison Joyce

Since Specialization
Citations

This map shows the geographic impact of Alison Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Joyce more than expected).

Fields of papers citing papers by Alison Joyce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Joyce. The network helps show where Alison Joyce may publish in the future.

Co-authorship network of co-authors of Alison Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Joyce. A scholar is included among the top collaborators of Alison Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Joyce. Alison Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joyce, Alison, et al.. (2022). Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response Maturation. The AAPS Journal. 24(6). 114–114. 9 indexed citations
2.
3.
Shea, Christopher M., et al.. (2021). Critical Reagent Characterization and Re-Evaluation to Ensure Long-Term Stability: Two Case Studies. Bioanalysis. 13(10). 807–815. 4 indexed citations
4.
Breen, Danna M., Hanna Kim, Donald Bennett, et al.. (2020). GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates. Cell Metabolism. 32(6). 938–950.e6. 115 indexed citations
5.
Padmanabhan, Shalini, Thomas A. Lanz, Donal Gorman, et al.. (2020). An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts. Journal of Parkinson s Disease. 10(2). 623–629. 29 indexed citations
6.
7.
Zhu, Liang, et al.. (2019). Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial Sampling. Pharmaceutical Research. 36(12). 169–169. 5 indexed citations
8.
Parng, Chuenlei, Susan Benard, Sunita Patel–Hett, et al.. (2019). In Vitro and In Vivo Characterization of Marstacimab, an Anti-TFPI Antibody. Blood. 134(Supplement_1). 2391–2391. 1 indexed citations
9.
Parng, Chuenlei, Jianqing Chen, Michael W. Bolt, et al.. (2017). Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa I16L. Journal of Pharmaceutical Sciences. 106(8). 2136–2143. 8 indexed citations
10.
Joyce, Alison, et al.. (2017). A Multi-site In-depth Evaluation of the Quanterix Simoa from a User’s Perspective. The AAPS Journal. 20(1). 10–10. 13 indexed citations
11.
Clark, Tracey, Phillip D. Yates, Alison Joyce, et al.. (2016). Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform. The AAPS Journal. 18(5). 1300–1308. 11 indexed citations
12.
Avery, Lindsay B., Mengmeng Wang, Alison Joyce, et al.. (2016). Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. mAbs. 8(6). 1064–1078. 70 indexed citations
13.
Wang, Mengmeng, Tetsuya Ishino, Alison Joyce, et al.. (2015). Faster in vivo clearance of human embryonic kidney than Chinese hamster ovary cell derived protein: Role of glycan mediated clearance. Journal of Bioscience and Bioengineering. 119(6). 657–660. 3 indexed citations
14.
Fischer, Saloumeh K, Alison Joyce, Mark Spengler, et al.. (2014). Emerging Technologies to Increase Ligand Binding Assay Sensitivity. The AAPS Journal. 17(1). 93–101. 65 indexed citations
15.
Chen, Jianqing, et al.. (2014). Comparison of Succinimidyl [125I]Iodobenzoate with Iodogen Iodination Methods to Study Pharmacokinetics and ADME of Biotherapeutics. Pharmaceutical Research. 31(10). 2810–2821. 15 indexed citations
16.
Joyce, Alison, et al.. (2014). One Mouse, One Pharmacokinetic Profile: Quantitative Whole Blood Serial Sampling for Biotherapeutics. Pharmaceutical Research. 31(7). 1823–1833. 42 indexed citations
17.
Joyce, Alison & Sheldon S. Leung. (2013). Use of response surface methods and path of steepest ascent to optimize ligand-binding assay sensitivity. Journal of Immunological Methods. 392(1-2). 12–23. 24 indexed citations
18.
Mallozzi, Cinzia, et al.. (2013). Bioanalytical platform comparison using a generic human IgG PK assay format. Journal of Immunological Methods. 397(1-2). 28–36. 21 indexed citations
19.
Ishino, Tetsuya, Mengmeng Wang, Lidia Mosyak, et al.. (2013). Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics. Journal of Biological Chemistry. 288(23). 16529–16537. 28 indexed citations
20.
Dudal, Sherri, Daniel Baltrukonis, Alison Joyce, et al.. (2013). Assay Formats: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. The AAPS Journal. 16(2). 194–205. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Hahn Breakdown of academic impact, for papers by Janine Woytschak Breakdown of academic impact, for papers by Alex D. Colella Breakdown of academic impact, for papers by Dae-Kyoung Choi Breakdown of academic impact, for papers by Andyna Vernet Breakdown of academic impact, for papers by C. Baerwald Breakdown of academic impact, for papers by Norikatsu Mizumoto Breakdown of academic impact, for papers by Wesley F. Obritsch Breakdown of academic impact, for papers by Divya Sagar Breakdown of academic impact, for papers by Leyre Falto‐Aizpurua
Rankless by CCL
2026